Mowery & Schoenfeld Wealth Management’s AbbVie ABBV Stock Holding History

Mowery & Schoenfeld Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$699K	Hold	2,778	–	–	0.95%	19
2026 Q1	$604K	Sell	2,778 -250	-8%	-$55.5K	0.92%	21
2025 Q4	$692K	Buy	3,028 +1,985	+190%	+$452K	1%	18
2025 Q3	$241K	Buy	1,043 +537	+106%	+$109K	0.41%	40
2025 Q2	$94K	Sell	506 -999	-66%	-$186K	0.14%	82
2025 Q1	$315K	Buy	1,505 +1,003	+200%	+$195K	0.62%	34
2024 Q4	$89.2K	Sell	502 -2,022	-80%	-$372K	0.17%	79
2024 Q3	$498K	Buy	2,524 +20	+0.8%	+$3.73K	0.79%	21
2024 Q2	$429K	Buy	2,504 +24	+1%	+$3.98K	0.62%	23
2024 Q1	$452K	Buy	+2,480	New	+$427K	0.87%	19

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mowery & Schoenfeld Wealth Management's ABBV Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,778 shares worth $699K. The position accounts for 0.95% of the portfolio, ranked #19.

Mowery & Schoenfeld Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mowery & Schoenfeld Wealth Management held 2,778 shares of AbbVie worth $699K as of Q2 2026.
Mowery & Schoenfeld Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.95% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #19 holding.
Mowery & Schoenfeld Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.